A leading US healthcare AI company has launched an advanced multi-cancer early detection system, leveraging artificial intelligence to identify over 50 cancer types from a single blood draw. This breakthrough technology promises to transform oncology by detecting cancers at earlier, more treatable stages — potentially revolutionizing how we approach cancer screening and prevention.

A leading US healthcare AI company has launched an advanced multi-cancer early detection system, leveraging artificial intelligence to identify over 50 cancer types from a single blood draw. This breakthrough technology promises to transform oncology by detecting cancers at earlier, more treatable stages — potentially revolutionizing how we approach cancer screening and prevention.